Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Daiichi Sankyo
UBS
US Army
Express Scripts
Teva
Harvard Business School
Argus Health
Queensland Health

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065013

« Back to Dashboard
NDA 065013 describes TOBRAMYCIN SULFATE, which is a drug marketed by Teva Pharms Usa, Mylan Labs Ltd, Hospira, West-ward Pharms Int, X Gen Pharms, Igi Labs Inc, Apothecon, Fresenius Kabi Usa, Watson Labs Inc, Claris, Akorn, and Xellia Pharms Aps, and is included in twenty-seven NDAs. It is available from nine suppliers. Additional details are available on the TOBRAMYCIN SULFATE profile page.

The generic ingredient in TOBRAMYCIN SULFATE is tobramycin sulfate. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

Summary for NDA: 065013

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 065013

Ingredient-typeAminoglycosides

Suppliers and Packaging for NDA: 065013

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION 065013 ANDA X-GEN Pharmaceuticals, Inc. 39822-0409 39822-0409-6 6 CARTON in 1 CARTON (39822-0409-6) > 1 VIAL in 1 CARTON (39822-0409-1) > 30 mL in 1 VIAL
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION 065013 ANDA X-GEN Pharmaceuticals, Inc. 39822-0412 39822-0412-1 1 VIAL in 1 CARTON (39822-0412-1) > 30 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1.2GM BASE/VIAL
Approval Date:Aug 17, 2001TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Teva
US Department of Justice
Fuji
McKesson
Daiichi Sankyo
Novartis
Colorcon
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot